The principal investigator allegedly did not follow U.S. Food and Drug Administration rules and regulations due to "mounting pressure to fast track [the drug] to market under exigent circumstances to meet artificial milestones set by BioXcel's biggest lenders Oaktree Capital Management, L.P. and Qatar Investment Authority," the complaint said.
January 12, 2024 at 03:06 PM
3 minute read
Litigation Reporter
BioXcel Therapeutics Inc. was named in a second shareholder derivative lawsuit after clinical trials for a neurological medication allegedly did not follow proper guidelines and the company allegedly made contrary statements to the public.
The complaint was surfaced on Law.com Radar.
Presented by BigVoodoo
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Credit: adimas/Adobe Stock
